The ApoB/ApoA-I ratio supersedes conventional lipids in predicting coronary artery disease and clinical phenotypes requiring revascularization
The ApoB/ApoA-I ratio is a superior biomarker for CHD risk stratification, particularly for identifying severe disease manifestations and guiding revascularization decisions in specific patient subgroups. Its integration into clinical practice could enable more precise cardiovascular risk management.
Authors
- Kunmei Chen
- Jinxin Fu
- Dongyu Hu (ORCID: https://orcid.org/0000-0002-2701-1864)
- Lei Li (ORCID: https://orcid.org/0000-0001-8723-3461)
- Li He
- Bingqing Zhou (ORCID: https://orcid.org/0000-0003-4305-5418)
- Yuanyuan Jiang
Institutions
- Army Medical University (CN)
- Daping Hospital (CN)
- Ministry of Education (TH)
Publication Details
- Journal
- Clinical and Experimental Hypertension
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1080/10641963.2025.2603463
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00